Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression
DOI: https://doi.org/10.2147/COPD.S383295
2023-04-09
International Journal of COPD
Abstract:Weimin Wang, 1, &ast Shaohong Zhang, 1, &ast Lei Cui, 2 Yu Chen, 2 Xingxing Xu, 2 Longchuan Wu 2 1 Department of Gerontology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, People's Republic of China; 2 Department of Respiratory Medicine, Huaian Hospital of Traditional Chinese Medicine, Affiliated to Nanjing University of Traditional Chinese Medicine, Huaian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Longchuan Wu; Xingxing Xu, Email ; Background: Bufei Yishen formula (BYF) is an effective prescription for the clinical treatment of chronic obstructive pulmonary disease (COPD). However, the molecular mechanism by which it exerts its pharmacological effects remains to be explored. Methods: The human bronchial cell line BEAS-2B was treated with cigarette smoke extract (CSE). Cellular senescence markers were detected by Western blot and ELISA. Potential transcription factor of klotho was predicted using JASPAR and USCS databases. Results: CSE induced cellular senescence with intracellular accumulation of cellular senescence biomarkers (p16, p21 and p27) and increased secretion of senescence-related secretory phenotypic (SASP) factors (IL-6, IL-8, and CCL3). In contrast, BYF treatment inhibited CSE-induced cellular senescence. CSE suppressed the transcription, expression and secretion of klotho, whereas BYF treatment rescued its transcription, expression and secretion. CSE downregulated the protein level of ZNF263, whereas BYF treatment rescued the expression of ZNF263. Furthermore, ZNF263-overexpressing BEAS-2B cells could inhibit CSE-induced cellular senescence and SASP factor secretion by upregulating the expression of klotho. Conclusion: This study revealed a novel pharmacological mechanism by which BYF alleviates clinical symptoms of COPD patients, and regulating ZNF263 and klotho expression may be beneficial to the treatment and prevention of COPD. Keywords: Bufei Yishen formula, cell senescence, ZNF263, klotho, senescence-related secretory phenotypic Chronic obstructive pulmonary disease (COPD) is a respiratory disease characterized by airflow limitation that is not fully reversible. COPD affects the health and lives of more than 300 million people worldwide and is the third leading cause of death worldwide after ischemic heart disease and stroke. 1 COPD imposes a huge economic and social burden and has become a major public health problem. In addition, its morbidity and mortality continue to rise. Currently, no pharmacological treatment is available to reduce the disease progression and mortality. Treatment strategies mainly focus on symptomatic treatment to improve the life quality of patient. 2 Bufei Yishen Formula (BYF) is an effective formula for the clinical treatment of COPD, which can effectively alleviate the clinical symptoms of patients, and improve their exercise tolerance and life quality. 3 In addition, it can reduce the severity, frequency, and volume of cough and improve wheezing symptoms. 3 However, the molecular mechanism by which BYF exerts its pharmacological effects remains to be explored. Cellular senescence is a state of irreversible permanent cell cycle arrest. Cyclin-dependent kinases inhibitory factors (p16, p21 and p27) accumulate in senescent cells. In addition, senescent cells secrete a variety of senescence-associated secretory phenotypes (SASP) of inflammatory proteins, leading to low-grade chronic inflammation. COPD is described as "accelerated lung aging disease". Accumulated senescent cells, including alveolar epithelial cells and endothelial cells, are found in the lungs of COPD patients. 4 The accumulation of senescent cells may lead to small airway fibrosis and alveolar cell loss in COPD patients. 5 Cigarette smoke exposure induced oxidative stress may be an important trigger of COPD aging. 6 To date, no studies have reported the effect of BYF on COPD-related cellular senescence. The klotho gene is a senescence suppressor gene that encodes a unidirectional transmembrane protein that has been shown to be a key regulator of oxidative stress and cellular senescence. Furthermore, the extracellular domain of the klotho protein can be cleaved and released as a soluble protein, which can be detected in cerebrospinal fluid and blood. Soluble klotho protein can act as an independent hormonal factor that regulates the activity of various growth factor signaling pathways (insulin/IGF-1 and Wnt) and various ion channels. It has been reported that the expression of klotho is significantly decreased in alveolar ma -Abstract Truncated-
respiratory system